CompletedNCT00271596
Citalopram or placebo and thinking skills in adults with Huntington disease
About this title
Read the official source — NCT00271596Medication studyAges 18–75United StatesADHD
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- Scottsdale and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateNovember 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 33
- Sponsor
- University of Iowa
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT00271596
- Official title
Show the full official title
A Randomized, Placebo-Controlled Pilot Study in Huntington's Disease (CIT-HD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Scottsdale · Iowa City · Rochester
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Iowa, a university.
Did this study involve medication?
Yes. The study involved medication, including 20mg daily citalopram and Placebo.
Who was this study for?
Listed age limits: 18 years to 75 years.
